Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

NCT02879513 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

290

Enrollment

OTHER

Sponsor class

Conditions

Invasive Ductal Breast Cancer
Tubular Breast Cancer
Mucinous Breast Cancer
Inflammatory Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: 5-fluoruracil

Sponsor

RenJi Hospital